(Q36573001)

15 August 2017

1 reference

title

The role of complement in autoimmune renal disease (English)

1 reference

15 August 2017

Seelen MA

1

1 reference

PubMed ID

16923541

15 August 2017

Daha MR

series ordinal

2

1 reference

15 August 2017

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

39

1 reference

15 August 2017

5

1 reference

15 August 2017

411-415

1 reference

Complement. Second of two parts

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Contrasting roles of complement activation and its regulation in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

The role of complement in the development of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

C1q, autoimmunity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Recognition and clearance of apoptotic cells: a role for complement and pentraxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Mannose-binding lectin engagement with late apoptotic and necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Therapeutic inhibition of the complement system. Y2K update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739688

10.1080/08916930600739688

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16923541